1,018
Views
2
CrossRef citations to date
0
Altmetric
Research Papers

Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue

, , , , , , , , , , & show all
Pages 1634-1640 | Received 23 Jan 2015, Accepted 08 Apr 2015, Published online: 06 Jul 2015

References

  • Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000; 18:743-53; PMID:10673515.
  • Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 2002; 38:27-43; PMID:11750837; http://dx.doi.org/10.1016/S0959-8049(01)00332-X.
  • Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 2004; 56:157-70; PMID:15016573; http://dx.doi.org/10.1016/S0022-3999(03)00371-4.
  • Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994; 38:383-92; PMID:7965927; http://dx.doi.org/10.1016/0022-3999(94)90099-X.
  • Irvine D, Vincent L, Graydon JE, Bubela N, Thompson L. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs 1994; 17:367-78; PMID:7954384; http://dx.doi.org/10.1097/00002820-199410000-00001.
  • Smets EM, Garssen B, Schuster-Uitterhoeve AL, de Haes JC. Fatigue in cancer patients. Br J Cancer 1993; 68:220-4; PMID:8347475; http://dx.doi.org/10.1038/bjc.1993.319.
  • Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 2006; 106:751-8; PMID:16400678; http://dx.doi.org/10.1002/cncr.21671.
  • Hjermstad MJ, Fossa SD, Oldervoll L, Holte H, Jacobsen AB, Loge JH. Fatigue in long-term Hodgkin's Disease survivors: a follow-up study. J Clin Oncol 2005; 23:6587-95; PMID:16170166; http://dx.doi.org/10.1200/JCO.2005.09.936.
  • Nieboer P, Buijs C, Rodenhuis S, Seynaeve C, Beex LV, van der Wall E, Richel DJ, Nooij MA, Voest EE, Hupperets P, et al. Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study. J Clin Oncol 2005; 23:8296-304; PMID:16219926; http://dx.doi.org/10.1200/JCO.2005.10.167.
  • Servaes P, Gielissen MF, Verhagen S, Bleijenberg G. The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psychooncology 2007; 16:787-95; PMID:17086555; http://dx.doi.org/10.1002/pon.1120.
  • Servaes P, Verhagen S, Schreuder HW, Veth RP, Bleijenberg G. Fatigue after treatment for malignant and benign bone and soft tissue tumors. J Pain Symptom Manage 2003; 26:1113-22; PMID:14654263; http://dx.doi.org/10.1016/j.jpainsymman.2003.03.001.
  • Bartsch HH, Weis J, Moser MT. Cancer-related fatigue in patients attending oncological rehabilitation programs: prevalence, patterns and predictors. Onkologie 2003; 26:51-7; PMID:12624518; http://dx.doi.org/10.1159/000069864.
  • Dimeo F, Schmittel A, Fietz T, Schwartz S, Kohler P, Boning D, Thiel E. Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann Oncol 2004; 15:1237-42; PMID:15277264; http://dx.doi.org/10.1093/annonc/mdh314.
  • Gielissen MF, Schattenberg AV, Verhagen CA, Rinkes MJ, Bremmers ME, Bleijenberg G. Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplant 2007; 39:595-603; PMID:17369868; http://dx.doi.org/10.1038/sj.bmt.1705624.
  • Okuyama T, Akechi T, Kugaya A, Okamura H, Shima Y, Maruguchi M, Hosaka T, Uchitomi Y. Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage 2000; 19:5-14; PMID:10687321; http://dx.doi.org/10.1016/S0885-3924(99)00138-4.
  • Servaes P, van der Werf S, Prins J, Verhagen S, Bleijenberg G. Fatigue in disease-free cancer patients compared with fatigue in patients with chronic fatigue syndrome. Support Care Cancer 2001; 9:11-7; PMID:11147137; http://dx.doi.org/10.1007/s005200000165.
  • Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC. Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum 1998; 25:915-20; PMID:9644708.
  • Gielissen MF, Verhagen S, Witjes F, Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol 2006; 24:4882-7; PMID:17050873; http://dx.doi.org/10.1200/JCO.2006.06.8270.
  • Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. Mechanisms of cancer-related fatigue. Oncologist 2007; 12 Suppl 1:22-34; PMID:17573453; http://dx.doi.org/10.1634/theoncologist.12-S1-22.
  • Schubert C, Hong S, Natarajan L, Mills PJ, Dimsdale JE. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun 2007; 21:413-27; PMID:17178209; http://dx.doi.org/10.1016/j.bbi.2006.11.004.
  • Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002; 64:604-11; PMID:12140350; http://dx.doi.org/10.1097/00006842-200207000-00010.
  • Kelley KW, Bluthe RM, Dantzer R, Zhou JH, Shen WH, Johnson RW, Broussard SR. Cytokine-induced sickness behavior. Brain Behav Immun 2003; 17 Suppl 1:S112-8; PMID:12615196; http://dx.doi.org/10.1016/S0889-1591(02)00077-6.
  • Gaab J, Rohleder N, Heitz V, Engert V, Schad T, Schurmeyer TH, Ehlert U. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinology 2005; 30:188-98; PMID:15471616; http://dx.doi.org/10.1016/j.psyneuen.2004.06.008.
  • Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, Pearce BD, Landry J, Glover S, McDaniel JS, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001; 158:1252-7; PMID:11481159; http://dx.doi.org/10.1176/appi.ajp.158.8.1252.
  • Prinsen H, de Vries IJ, Torensma R, Pots JM, Mulder SF, van Herpen CM, Elving LD, Bleijenberg G, Stelma FF, van Laarhoven HW. Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome. BMC immunol 2012; 13:71; PMID:23244635; http://dx.doi.org/10.1186/1471-2172-13-71.
  • Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992; 148:1143-8; PMID:1737931.
  • Levings MK, Sangregorio R, Roncarolo MG. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001; 193:1295-302; PMID:11390436; http://dx.doi.org/10.1084/jem.193.11.1295.
  • Liao W, Lin JX, Leonard WJ. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 2011; 23:598-604; PMID:21889323; http://dx.doi.org/10.1016/j.coi.2011.08.003.
  • Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 2012; 12:180-90; PMID:22343569.
  • Pukhal'skii AL, Shmarina GV, Aleshkin VA. [Regulatory T-cells: modern approaches to optimization of their numbers]. Vestn Ross Akad Med Nauk 2011:24-33; PMID:21950132.
  • Csermely P, Schnaider T, Soti C, Prohaszka Z, Nardai G. The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol Ther 1998; 79:129-68; PMID:9749880; http://dx.doi.org/10.1016/S0163-7258(98)00013-8.
  • de Zoeten EF, Wang L, Butler K, Beier UH, Akimova T, Sai H, Bradner JE, Mazitschek R, Kozikowski AP, Matthias P, et al. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells. Mol Cell Biol 2011; 31:2066-78; PMID:21444725; http://dx.doi.org/10.1128/MCB.05155-11.
  • Mulder SF, Jacobs JF, Olde Nordkamp MA, Galama JM, Desar IM, Torensma R, Teerenstra S, Mulders PF, Vissers KC, Punt CJ, et al. Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination. Clin Cancer Res 2011; 17:4541-9; PMID:21712444; http://dx.doi.org/10.1158/1078-0432.CCR-11-0253.
  • Gielissen MF, Verhagen CA, Bleijenberg G. Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer 2007; 97:612-8; PMID:17653075; http://dx.doi.org/10.1038/sj.bjc.6603899.
  • Servaes P, Verhagen S, Bleijenberg G. Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol 2002; 13:589-98; PMID:12056710; http://dx.doi.org/10.1093/annonc/mdf082.
  • de Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, Osterhaus AD. Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 2003; 115:63-73; PMID:15088777.
  • Pollyea DA, Brown JM, Horning SJ. Utility of influenza vaccination for oncology patients. J Clin Oncol 2010; 28:2481-90; PMID:20385981; http://dx.doi.org/10.1200/JCO.2009.26.6908.